Fabrication of Polyvalent Therapeutic RNA Nanoparticles for Specific Delivery of siRNA, Ribozyme and Drugs to Targeted Cells for Cancer Therapy.
Bacteriophage phi29 DNA packaging motor is geared by a six-pRNA ring. pRNA is able to form a multimeric complex and patterned superstructures via the interaction of two reengineered interlocking loops. This unique feature makes it an ideal polyvalent vehicle for nanomachine fabrication, pathogen detection, and the delivery of therapeutics. This report describes novel approaches for the fabrication of polyvalent therapeutic pRNA nanoparticles, especially tetramers for specific siRNA delivery to cancer cells and for the silencing of targeted genes. RNA 3-D design, circular permutation, folding energy alteration, and nucleotide modification were applied to generate stable RNA nanoparticles with low toxicity. Animal trials demonstrated the high efficiency of the polyvalent RNA nanoparticles in the prevention and treatment of cancer. Using such protein-free nanoparticles as therapeutic reagents would allow for long-term administration to avoid the induction of antibody due to repeated treatment for chronic diseases.
Department of Biomedical Engineering, College of Medicine/College of Engineering, University of Cincinnati, 3125 Eden Ave., Cincinnati, OH, USA.
Yi
Y
Shu
Dan
D
Shu
Zhijuan
Z
Diao
Guanxin
G
Shen
Peixuan
P
Guo
Bioconjug Chem. 2001 Nov-Dec;12(6):939-48
11716685
RNA. 1997 Sep;3(9):1068-79
9292504
Science. 2004 Oct 15;306(5695):419-20
15486279
J Biol Chem. 1994 Feb 4;269(5):3198-204
8106354
Nucleic Acids Res. 1987 Nov 11;15(21):8783-98
3684574
Adv Drug Deliv Rev. 2000 Mar 30;41(2):147-62
10699311
Nano Lett. 2004 Sep;4(9):1717-23
21171616
Virology. 1995 Mar 10;207(2):442-51
7533964
Angew Chem Int Ed Engl. 2000 Jul 17;39(14):2521-2524
10941124
Gene. 1993 Mar 30;125(2):111-4
7681803
J Control Release. 2003 Aug 28;91(1-2):17-29
12932634
Hum Gene Ther. 2005 Sep;16(9):1097-109
16149908
Science. 1993 Aug 6;261(5122):762-5
7688143
J Biol Chem. 1994 Feb 18;269(7):5157-62
8106496
J Mol Biol. 2006 Feb 24;356(3):589-99
16376938
J Mol Biol. 2008 Sep 19;381(5):1114-32
18674782
Nature. 2001 May 24;411(6836):494-8
11373684
J Biol Chem. 2000 Jun 9;275(23):17510-6
10748150
Curr Opin Struct Biol. 2006 Aug;16(4):531-43
16843653
J Biol Chem. 1994 Jul 15;269(28):18656-61
8034614
Science. 2002 May 17;296(5571):1319-21
12016316
Nature. 2002 Jul 25;418(6896):379-80
12140542
Science. 1990 Aug 3;249(4968):505-10
2200121
Nucleic Acids Res. 1978 Oct;5(10):3665-77
724498
Gene Ther. 2003 Aug;10(15):1258-67
12858191
Nature. 1990 Aug 30;346(6287):818-22
1697402
Cancer Biol Ther. 2007 May;6(5):697-704
17426446
Virology. 1994 May 15;201(1):77-85
8178491
Nature. 2003 Jan 23;421(6921):427-31
12540916
J Nanosci Nanotechnol. 2005 Dec;5(12):1964-82
16430131
Gene Ther. 2006 May;13(10):814-20
16482206
Mol Cell. 1998 Jul;2(1):149-55
9702202
Nano Lett. 2005 Sep;5(9):1797-808
16159227
Microbiol Mol Biol Rev. 1998 Dec;62(4):1415-34
9841677
RNA. 2003 Dec;9(12):1562-70
14624011
J Nanosci Nanotechnol. 2003 Aug;3(4):295-302
14598442
J Biol Chem. 2002 Jun 7;277(23):20794-803
11886855
J Nucl Med. 1996 Jun;37(6):1003-8
8683292
Science. 2002 Apr 19;296(5567):550-3
11910072
RNA. 1997 Mar;3(3):315-23
9056768
Chem Rev. 2005 Apr;105(4):1171-96
15826012
Curr Opin Struct Biol. 2006 Jun;16(3):279-87
16713707